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EditorialThe therapeutic value of natural products derived from Chinese
medicine—A systems based perspective
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aThe research and development pipeline for new drugs is a
hallenge and increasingly there is a focus on the potential of nat-
ral products as sources for new pharmaceuticals [1]. Powerful
nalytical tools and technologies such as genomics, proteomics,
etabolomics, bioinformatics and provide new opportunities to
dentify and characterise such products. The benefits of using
omics’ technologies help to ensure that robust ethno-botanical
nd ethno-medical studies in traditional medicines may help
o provide inexpensive, accessible, safe and reliable new and
mproved medicines and treatments. However, modern natu-
al product chemistry should not be detached from traditional
ractice, respecting the indigenous nature, use and availability
f products. If the value of natural products is to be recog-
ised, this needs to be optimised through multidisciplinary and
nternational collaboration.
Good Practice in Traditional Chinese Medicine (GP-TCM)
nitiative http://project.gp-tcm.org/ was a European Coordina-
ion Action funded under the 7th framework programme. The
verall aim of the project was to inform best practice and
armonise research on the quality, safety and efficacy of Tra-
itional Chinese Medicine (TCM) in EU Member States using a
unctional genomics approach, facilitated through exchange of
pinions, experience and expertise among scientists in Europe
nd China [1]. Although the project ended in October 2012 with
he publication of a special issue of the Journal of Ethnophar-
acology [2], the GP-TCM consortium has continued to be
sustainable organisation by developing into the GP-TCM
esearch Association in order to further encourage these goals
nd by developing the Association to expand this European-
hinese network globally [3].
Special interest groups have been set up for Quality
ontrol, Pharmacology and Toxicology, Clinical Stud-
es, Regulatory Affairs, and Acupuncture, which reflect
he key areas initially considered in the initial project
ttp://www.gp-tcm.org/work-packages/. These groups are
ctive in proposing standard protocols for methodology, and
rioritising areas for future research. TCM uses a unique theo-
etical system and has an individualised and holistic approach
o describe health and disease, based on the philosophy of
m
t
f
ttp://dx.doi.org/10.1016/j.eujim.2014.09.132
876-3820/© 2014 The Authors. Published by Elsevier GmbH. This is an open a
icenses/by-nc-nd/3.0/).balance of Yin-Yang. GP-TCM RA aims to promote best
ractice in research on quality, safety and efficacy of TCM,
n particular inform best practice, and harmonise research of
afety and efficacy of TCM, in particular in Chinese herbal
edicines and acupuncture.
The 3rd Annual meeting of the GP-TCM Research Associ-
tion was held in Nanjing, China in July 2014 in conjunction
ith the 5th annual Conference of the Speciality committee of
he TCM Pharmaceutical Analysis of the WFCMS. Organised
y the China Pharmaceutical University (CPA) and the Shanghai
nstitute of Materia Medica (SIMM), it attracted over 380 partic-
pants from 16 countries including: China, United States, United
ingdom, Canada, Germany, The Netherlands, Austria, Japan,
ndia and South Africa.
Participants presented their recent research in traditional Chi-
ese medicine and other traditional medicine systems. These
bstracts are published in this issue of EuJIM and show case
nly some of the wealth of research being conducted in China
nd worldwide on TCM and include abstracts from the 8 plenary
ectures and 45 invited speakers [4]. The conference covered an
rray of topics including chemistry, quality, pharmacology, toxi-
ology, clinical studies, systems biology, regulatory affairs, new
rug discovery.
The regulatory status for traditional medicines/herbal
edicines in different countries was presented and discussed
n depth. Dr. Werner Knöss, the Chairperson of Committee
n Herbal Medicinal Products, European Medicines Agency,
elivered the opening keynote introducing the current regula-
ory framework of herbal medicinal products in the EU. His
alk, “European Regulatory Framework for Herbal Medicinal
roducts – Challenges for Traditional Medicines” described
he registration and regulatory framework for herbal medicines,
specially for traditional medicines in EMA. Different tradi-
ions in the Member States of the EU are being harmonized
y European community monographs and European legislation
lso provides professional options for non-European traditional
edicines. But it was pointed out that great challenges in access
o the market were facing traditional medicinal products. A pro-
essional strategy which fulfils the current European technical
ccess article under the CC BY-NC-ND license (http://creativecommons.org/
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equirements on quality, efficacy and safety of medicinal prod-
cts is required. The questions and answers regarding traditional
edicinal products market access in The Netherlands was pre-
ented by Dr Emiel Van Galen, the head of the Herbal Medicine
epartment of Medicines Evaluation Board of The Netherlands.
e exemplified the successful registration of a TCM herbal
roduct called Diao Xin Xue Kang, coated capsules (Dioscorea
ipponica rhizoma, dry extract) by Dutch medicines authority
n March 14th of 2012. This is the first and only TCM prod-
ct registered in Europe to date after the release of Directive
004/24/EC of The European Parliament and of the Council in
004. The registration procedure and experience of this approved
CM product could be treated as a model for other TCM herbal
roducts for registration in Europe and definitely is a great
ncouragement for other intentional manufacturers in China.
he similarities and differences in the market access and regu-
atory requirements for Herbal Products in Europe and the USA
ere further discussed by Dr Thomas Brendler.
Elaboration of quality standards in different Pharmacopoeias
s well as the new approaches for herbal quality control was
nother topic which was comprehensively discussed. Prof. Ger-
ard Franz, the chairman of TCM working party of European
harmacopoeia delivered a lecture on the status report of TCM
erbal drug quality monographs in Europe. He detailed the
nclusion criteria of Chinese herbal drugs in the TCM Herbal
rug Working Program of the European Pharmacopoeia and
lso the elaboration procedures of these monographs. Clearly
hallenges were still remained for the elaboration process, espe-
ially for those processed (Paozhi) TCM herbal drugs. So far, 45
CM herbal quality monographs have been adopted European
harmacopoeia with 30 more herbs are still in the drafting pro-
ess. Dr Shang-mei Shi, director of TCM department, Chinese
harmacopoeia, introduced the recent development of TCM
uality standards in Chinese Pharmacopoeia and the progress
n the ongoing publication of 2015 edition of Chinese Pharma-
opoeia. New approaches and methodologies for herbal analysis
nd quality control were also extensively discussed in the sec-
ion dedicated to chemistry and quality of herbal medicines,
uch as ambient mass spectrometry, linear calibration using two
eference substances for overall quality control, capillary elec-
romigration, supercritical fluid chromatography, chemometric
odelling of analytical data, multiple mass spectrometry-based
lycomic approach, methods for identification of chemical
arkers, approach for quality control of complex herbal for-
ulas.
There were also many lectures covering a wide variety of
hemes on traditional medicine/natural medicines, systems biol-
gy, toxicology, pharmacokinetics, modern research on TCM
heory, action mechanisms. There was also a specific emphasis
n the new drug discovery using traditional medicine/natural
edicine as resources, in which quite a few new drugs or drug
andidates of this type were developed or in the process of
evelopment.Acupuncture is a key component of TCM and consists of
timulating specific acupuncture points by the insertion of
ne needles into the skin in order to correct imbalances in the
ow of qi/ energy through channels or meridians in the body.
m
e
i
otive Medicine 6 (2014) 617–620
cupuncture also featured in this conference with presentations
n the current state of the evidence base.
Moxibustion, an integral part of traditional Chinese medicine
TCM), is a technique that applies heat using a herbal
reparation, Artemisia vulgaris, for acupuncture point stim-
lation. Possible mechanisms of action have focussed on
nti-inflammation and immunoregulation theories. Although
sed as an intervention for a wide range of conditions, research
n moxibustion has mainly been carried out in China. In this
ssue, the systematic review by Sun et al. [5] on moxibustion
or treating rheumatoid arthritis has been chosen as the ‘Edi-
ors choice’, partly to further stimulate research on this under
esearched topic which is part of common clinical practice.
sing seven Chinese and English databases eight RCTs met the
nclusion criteria. These trials were mostly of low methodologi-
al quality with high risk of bias, but meta-analysis suggested
here were beneficial effects when using moxibustion, either
lone or the combination with Western medicine for rheumatoid
rthritis. Results should be interpreted with caution but hope-
ully it will encourage others to start to carry out research in this
rea.
There are few studies on the relationship between the use of
ilates and quality of life. Rodríguez-Fuentes et al.’s [6] before
nd after study indicates that there were benefits in terms of
hysical and mental health related quality of life (as measured
y the SF-36), for climacteric women who took part in a 12
eek Pilates programme. Although observational in nature, the
uthors recognise that further research should include a control
roup and long-term follow-up to assess whether any positive
esults can be maintained.
There is a real global concern about the trend to grow-
ng antibiotic resistance. ReDuNing (RDN), is a patented
raditional Chinese medicine, widely used as both an anti-
nflammatory and as an anti-infective. Experimental data on its
se against influenza viruses and viral pneumonia is limited.
study reported in this issue demonstrates significant changes
n histopathology, lung index, nucleoprotein (NP) gene expres-
ions and inflammatory markers against H1N1 influenza virus
fter RDN administration to restraint-stressed mice [7]. This is
n area where natural product development could have great
mportance in coming years.
Inflammatory bowel disease (IBD) is characterised by
hronic inflammation. Current conventional pharmaceutical
anagement is often associated with unacceptable adverse
ffects which may limit their use especially for prolonged treat-
ent. Triphala is a popular traditional Ayurvedic formulation
sed to treat various diseases. It consists of a mixture of vari-
us powdered dried fruits and is known to possess free radical
cavenging activity and is traditionally used as protective agent
or the gastrointestinal tract. In a laboratory assay, aqueous
riphala extract was assessed for Nitric oxide (NO) scavenging
nd anti-lipid peroxidation activities [8]. The authors suggest
hat Triphala may become can be a very useful treatment for
anaging IBD, promote gut health and may have potential ben-
ficial actions for use in colorectal cancer given that normal
ssue architecture was restored, a reduction in inflammation was
bserved and there were changes in gene expression.
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Exposure to stress during pregnancy has adverse effects
n pregnancy outcomes such as low birth weight, sponta-
eous abortion and premature delivery. The growing therapeutic
mportance of the natural products such as honey is exam-
ned in study on pregnant rats subjected to restraint stress [9].
he authors report that supplementation of honey significantly
mproved changes in serum corticosterone level, adrenal gland
istomorphometry and pregnancy outcomes in rats suggesting
hat honey has a protective effect. They suggest extending this
esearch to investigate whether there is a possible benefit to
sing honey as a supplement to improve pregnancy outcomes
or pregnant women who are exposed to stress.
Chagas disease caused by Trypanosoma cruzi, is endemic in
atin America, but also affects many people worldwide. Treat-
ent is limited and has poor efficacy when the disease is chronic
nd also has adverse effects associated with it. Although often
ontroversial, homoeopathy has been seen as safe and inex-
ensive as a treatment for various conditions as the possible
echanisms of action remain to be substantiated. Biotherapies
re highly diluted medications that are prepared in accordance
ith homoeopathic pharmaco-technical methods. A Brazilian
tudy [10] in this issue determines the therapeutic responsive-
ess ofbiotherapy7dH toChagas disease using a mouse model.
he study reports that the administration of T. cruzi biotherapy
dH 30 days before infection altered the experimental course
f infection by T. cruzi and haematological parameters. More
tudies are required to confirm these findings.
The effect of Elaeagnus angustifolia L. whole fruit and
edulla powders on clinical symptoms of women with
steoarthritis (OA) of the knee was investigated in this 3 armed
lacebo controlled double blind RCT carried out in Iran [11].
ignificant differences between the patients receiving medulla
owder and the placebo group were observed in terms of changes
n pain and physical function scores as assessed by the WOMAC
ndex but not with the whole fruit powder when compared with
lacebo.
Stroke is a major cause of death and disability in world-
ide. A traditional Korean medicine stroke prevention education ative Medicine 6 (2014) 617–620 619
rogramme (TKM-SPEP), evaluated the awareness of the symp-
oms of stroke in a group of elderly people living in Korea before
nd after taking part in the programme [12]. The TKM-SPEP
rought about positive changes with respect to participants’
nowledge about stroke; but more specific areas, such as the
eported exercise levels and management of risk factors, did not
hange significantly. Prevention requires more sustained effort
lobally in order to identify appropriate approaches to improve
nowledge and health outcomes.
This is the last issue of EuJIM for 2014, next year watch out
or our special issues.
The next exciting Special issue, Traditional and Integra-
ive Approaches for Global Health (co-edited by Prof Torkel
alkenberg, Karolinska Institute, Sweden and Dr Michael Smith,
amueli Institute, USA), will be issued early 2015.
In addition, our new Special issue calls include:
Diagnostic Techniques and Outcome Measures for Inte-
grated Health (co-edited by Prof Sarah Stewart Brown,
University of Warwick and Dr Myeong Soo Lee, Korea Insti-
tute of Oriental Medicine) – Closing date for submissions 31
March 2015
Complementary Medicine for Sexual and Reproductive
Health (Lead editor – Prof Waris Qidwai, Department of
Family Medicine, Aga Khan University, Pakistan, co-editors;
Kashmira Nanji Aga Khan University, Dr William Wong,
Department of Family Medicine and Primary Care, The Uni-
versity of Hong Kong) – Closing date for submissions – 30
April 2015.
Paediatric Integrative Medicine (co-edited by Prof Sunita
Vohra, University of Alberta, Canada, Dr Paula Gardiner,
Boston University School of Medicine, USA, Prof Kathi
Kemper, Ohio State University) – Closing date for submis-
sions 1 June 2015.
We look forward to receiving your submissions. Please look
t the website for further details www.elsevier.com/eujim
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